
Lyophilization Vial
RTS glass vials
Lyophilization
Depyrogenated
Three-stage wash
USP / EP compliant
RTD · Ready to deliver
- Fast Delievery
- Quality Assurance
- 24/7 Customer Service
Full Customization
Description
RTS · DEPYROGENATED · READY-TO-DELIVER
RTD / DEPYRO / USP-EP / LYO

RTS
Glass
Vials for
Lyophilization
Depyrogenated · Three-stage washed · USP / EP compliant · RTD
Ready-to-sterilise (RTS) depyrogenated glass vials for pharmaceutical lyophilisation applications - triple-purified water washed, heat-depyrogenated, and delivered as ready-to-deliver (RTD) components. Compliant with USP and EP standards. Paired with pre-washed bromobutyl rubber stoppers, third-party endotoxin and bioburden tested, with full validation support documentation available.
RTS glass vials
Lyophilization
RTD · Ready to deliver
USP / EP compliant
3-Stage
Water wash
300°C
Depyrogenation
RTD
Ready to deliver
3rd Party
Tested · CoA available
CLEAN & DEPYROGENATION PROCESS
From raw glass to pharmaceutical-grade clean
Every vial undergoes a validated three-stage purified water washing sequence followed by high-temperature depyrogenation, achieving the cleanliness and endotoxin reduction standards required for lyophilisation applications.
Recirculated purified water (PW)
Initial rinse with recirculated pharmaceutical-grade purified water (USP Purified Water). Removes gross particulate matter, dust, and processing residues from the internal and external glass surfaces. Water is monitored for conductivity and microbial limits throughout the cycle.
USP Purified Water
01
Water for Injection (WFI)
The primary wash cycle uses Water for Injection (WFI) - the highest purity water grade in pharmaceutical processing, with endotoxin limits of ≤ 0.25 EU/mL (USP/EP). This stage eliminates ionic contamination, organic residues, and the majority of endotoxin burden from glass surfaces.
WFI · ≤0.25 EU/mL
02
Final WFI flush
A final fresh WFI flush cycle ensures no carry-over from previous stages and confirms a clean rinse water profile on the last pass. Rinse water samples are retained and tested for endotoxin, conductivity, and TOC (Total Organic Carbon) as part of the process qualification record.
Final WFI flush · TOC tested
03
≥ 300 °C dry-heat tunnel
Washed vials pass through a dry-heat depyrogenation tunnel at ≥ 300 °C. This achieves a minimum 3-log reduction in bacterial endotoxin (LRE ≥ 3), compliant with the USP <1211> and EP 5.1.1 depyrogenation validation requirements. The heat exposure also provides simultaneous sterilisation. Temperature mapping and challenge studies are documented and available.
≥300 °C · LRE ≥3 log
04
Vial specifications
RTS glass vials - product detail
Depyrogenated Type I borosilicate glass vials for lyophilisation, supplied ready-to-deliver. Available in standard pharmaceutical formats matched to common lyophilisation equipment tray configurations.

| size | outer diameter | vial height | nest box | PP soft box | ||
| pcs/box |
pcs/CTN |
pcs/box | pcs/CTN | |||
| 2R/2ml | 16+0.15mm | 35±0.5mm | 120 | 1200 | 500 | 2500 |
| 4R/4ml | 16+0.15mm | 45±0.5mm | 120 | 1200 | 500 | 2000 |
| 6R/6ml | 22+0.2mm | 40±0.5mm | 56 | 560 | 266 | 1064 |
| 8R/8ml | 22+0.2mm | 45±0.5mm | 56 | 560 | 266 | 1064 |
| 10R/10ml | 24+0.2mm | 45±0.5mm | 56 | 560 | 228 | 912 |
| 15R/15ml | 24+0.2mm | 60±0.5mm | 56 | 560 | 228 | 684 |
| 20R/20ml | 30+0.25mm | 55±0.5mm | 30 | 300 | 140 | 420 |
| 25R/25ml | 30+0.25mm | 65±0.5mm | 30 | 300 | 140 | 420 |
| 30R/30ml | 30+0.25mm | 75±0.5mm | 30 | 300 | 140 | 420 |
| 2ml | 16+0.15mm | 31±0.5mm | 120 | 1200 | 500 | 2500 |
| 10ml | 22+0.2mm | 50±0.5mm | 56 | 560 | 266 | 1064 |
| 8ml | 24+0.2mm | 40±0.5mm | 56 | 560 | 228 | 912 |
| 20ml | 28+0.3mm | 55±0.5mm | 30 | 300 | 160 | 480 |
| 25ml | 28+0.3mm | 65±0.5mm | 30 | 300 | 160 | 480 |
| 30ml | 32+0.3mm | 70±0.5mm | 30 | 300 | 113 | 339 |

Product name |
RTS Lyo Glass Vials |
| Designation | Ready-to-Sterilise (RTS) / RTD |
| Glass material | Type I borosilicate |
| Hydrolytic class | Class I (USP) / Type I (EP) |
| Application | Lyophilisation (freeze-drying) |
| Washing | Three-stage PW + WFI |
| Depyrogenation | ≥ 300 °C dry-heat tunnel |
| Endotoxin limit | ≤ 0.25 EU/vial (post-process) |
| Particulate matter | USP <788> / EP 2.9.19 compliant |
| Surface treatment | Siliconised (if specified) |
| Delivery condition | RTD - ready to deliver |
| Packaging | Nested tray or pp bag |
| Lot traceability | Full lot documentation included |
| CoA | Available with each shipment |
Purpose-built for lyophilisation
The vial geometry - neck diameter, body height, and bottom profile - is optimised for lyophilisation process requirements: heat transfer uniformity across the shelf surface, consistent headspace for sublimation, and compatibility with standard lyo stopper insertion and stoppering mechanisms.
Type I borosilicate - pharmacopoeial grade
Type I borosilicate glass provides the lowest extractable and leachable profile of any pharmaceutical glass type - meeting the chemical resistance requirements of USP Type I and EP Type I classification. Safe for injectable preparations, pH-sensitive formulations, and protein biologics.
RTD - no further preparation required
RTS vials are supplied in a ready-to-deliver (RTD) condition - washed, depyrogenated, and packaged under cleanroom conditions. They can proceed directly to your lyo filling line without additional washing or depyrogenation steps, subject to your site's incoming inspection process.
VALIDATION SUPPORT
your regulatory filing
we provide a comprehensive validation support package with each product lot-covering the documentation your QA and requlatory teams need to quality our components as a supplier and incorporate them into your pharmaceutical batch records
Lot-level · Test results · Specs
A full Certificate of Analysis is issued for every production lot, confirming compliance with all applicable USP and EP requirements including hydrolytic resistance, particulate matter, dimensional specification, and endotoxin test results.
Hydrolytic resistance (USP Type I / EP Type I)
Particulate matter (USP <788> / EP 2.9.19)
Endotoxin (BET - LAL method)
Dimensional inspection report
Lot number and traceability chain
Process qualification · LRE data
The dry-heat depyrogenation tunnel process is fully validated, with documented temperature mapping studies, challenge studies using Lipopolysaccharide (LPS) endotoxin, and demonstrated ≥ 3-log reduction in endotoxin (LRE ≥ 3) - meeting USP <1211> and EP 5.1.1 requirements.
Temperature mapping (IQ/OQ/PQ documented)
LRE ≥ 3-log challenge study data
USP <1211> compliance statement
EP 5.1.1 compliance statement
Tunnel calibration and maintenance records
Audit support · DMF · Quality agreement
Our supplier qualification package supports your incoming inspection, approved supplier list maintenance, and audit programme. Available documentation includes a Drug Master File (DMF) reference, quality agreement template, and site master file information on request.
Drug Master File (DMF) reference
Quality agreement available
Site audit questionnaire
Manufacturing site information
Change notification procedure

Ready to qualify our vials
for your lyophilisation line?
Request validation documentation, CoA samples, or a product quote.
We respond within 24 hours.
If you need pre-sterilised vials, stoppers, seals, instead of pre-washed, specify at enquiry stage and we will confirm availability and pricing.
Hot Tags: lyophilization vial, China lyophilization vial manufacturers, suppliers
Send Inquiry
You Might Also Like






